Key result
A 49-year-old female developed stress cardiomyopathy following a COPD exacerbation and multiple albuterol treatments, with left ventricular function improving after 3 days.
Case Report (n=1)
Highlights the clinical challenge of managing bronchospasm with catecholamines (albuterol) in patients who develop stress cardiomyopathy.
May raise awareness of COPD exacerbation as possible takotsubo trigger; hypothesis-generating and should not yet change practice.
Introduction. Stress cardiomyopathy, or takotsubo cardiomyopathy, is an acute, reversible left ventricular dysfunction usually initiated by a psychological or physical stress. We report this case of stress cardiomyopathy following a chronic obstructive pulmonary disease exacerbation and the subsequent treatment. Case Description. A 49-year-old white female with a history of chronic obstructive pulmonary disease presented to the emergency room via emergency medical services with worsening severe shortness of breath and productive cough for 2 weeks but denied any chest pain on arrival. On presentation, she was noted to be tachypneic, using her accessory muscles and with bilateral coarse expiratory wheezing on lung auscultation. Initial electrocardiogram demonstrated sinus tachycardia. She was treated with multiple albuterol treatments. Soon afterwards, the course was complicated by hypoxic respiratory failure eventually requiring intubation. Her repeat electrocardiogram showed acute changes consistent with myocardial infarction, and an echocardiograph demonstrated apical akinesia with an ejection fraction of 25% to 30%. The patient was urgently taken for cardiac catheterization, which showed no angiographic evidence of coronary artery disease. Three days after initial presentation, a repeat transthoracic echocardiogram showed overall left ventricular systolic function improvement. Discussion. This case provided a unique look at the difficulty of balancing catecholamines in a patient with bronchospasm and stress cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Landefeld et al. (2015) conducted a case report in Stress cardiomyopathy and COPD exacerbation (n=1). Albuterol treatments was evaluated. A 49-year-old female developed stress cardiomyopathy following a COPD exacerbation and multiple albuterol treatments, with left ventricular function improving after 3 days.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: